心脏手术术前贫血:术前评估、治疗与结局
Preoperative anaemia in cardiac surgery: preoperative assessment, treatment and outcome.
PubMed 文献 · Br J Anaesth · 2022-01-24
术前贫血在心脏手术患者中常见,与术后并发症和死亡率增加相关。及时诊断和治疗术前贫血可能是围术期风险分层和优化的合理目标,但将贫血治疗纳入临床常规仍具挑战性,且改善结局的证据目前有限。
要点
- 术前贫血在心脏手术患者中常见,与术后并发症和死亡率增加相关。
- 及时诊断和治疗术前贫血可能是围术期风险分层和优化的合理目标。
- 将贫血治疗纳入临床常规仍具挑战性,改善结局的证据目前有限。
核心结论
- 术前贫血在心脏手术患者中常见,与术后并发症和死亡率增加相关。
- 及时诊断和治疗术前贫血可能是围术期风险分层和优化的合理目标。
主要发现
- 术前贫血与心脏手术后并发症和死亡率增加相关。
临床怎么用
- 对心脏手术患者进行术前贫血的及时诊断和治疗,可能有助于围术期风险分层和优化。
局限性
- 将贫血治疗纳入临床常规仍具挑战性,且改善结局的证据目前有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preoperative anaemia is common and associated with increased postoperative morbidity and mortality after cardiac surgery. These findings are supported by a large Dutch cohort study including >35 000 patients published in this issue of the British Journal of Anaesthesia. Timely diagnosis and preoperative anaemia treatment seem to be reasonable targets for perioperative risk stratification and modification. However, implementation of anaemia therapy into clinical routines remains challenging, and evidence for improved outcome is currently limited.
来源:Br J Anaesth,查看原文。版权归原作者所有。
引用
- Bolliger D, Mauermann E, Buser A, et al. Preoperative anaemia in cardiac surgery: preoperative assessment, treatment and outcome. Br J Anaesth. 2022. PMID: 35086686. doi:10.1016/j.bja.2021.12.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。